📰 Arch News
Page 719 - Arch News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Arch. Real-time updates on events, politics, business and more.
April 4, 2023
Disclosure of trading in own shares under a share buyback programme Period : From 27 March 2023 to 31 March 2023 Issuer’s registered name: Ipsos Issuer’s Identification code:... | April 4, 2023
April 4, 2023
The CAC 40 Index is down 1.00 point or 0.01% today to 7344.96 --Largest one day point and percentage decline since Friday, March 24, 2023 --Snaps a six trading day winning streak ... | April 4, 2023
April 4, 2023
The STOXX Europe 600 Index is down 0.38 point or 0.08% today to 457.34 --Largest one day point and percentage decline since Friday, March 24, 2023 --Down for two consecutive trading... | April 4, 2023
April 4, 2023
Elica Spa reports that it purchased 16,983 treasury shares in the period between March 13 and March 30, 2023. The shares were taken over at a weighted average price of EUR2.86 per share, for a total... | April 4, 2023
April 4, 2023
Regulatory News: In accordance with the provisions concerning voting rights contained in Article L.233-8 II of the French Commercial Code and Article 223-16 of the AMF's general regulations, SFL (Paris:FLY)
April 4, 2023
On March 15th, CNN Business reported that the Federal Reserve has created a new rescue plan to prevent another SVB-like collapse from occurring. The new plan, titled the Bank Term Lending Program ,... | April 4, 2023
April 4, 2023
Nantes (France) - 4 April 2023 - 6.00 pm - Lhyfe (Euronext Paris - FR0014009YQ1 - LHYFE), an independent green hydrogen producer for low carbon industry and mobility, informs to the total number of
April 4, 2023
Front Month Comex Silver for April delivery gained $1.0810 per troy ounce, or 4.52% to $25.022 today --Largest one day dollar and percentage gain since Monday, March 13, 2023 --Up 10... | April 4, 2023
April 4, 2023
FOR IMMEDIATE RELEASE Disclosure Of Trading In Own SharesFor February 2023 CLICHY – March 09, 2023 In... | April 4, 2023
April 4, 2023
WALTHAM - ImmunoGen, Inc., a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that on March 31, 2023, the Compensation Committee of the... | April 4, 2023